Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Closing the Gap in Surveillance and Audit of Invasive Mold Diseases for Antifungal Stewardship Using Machine Learning.

Baggio D, Peel T, Peleg AY, Avery S, Prayaga M, Foo M, Haffari G, Liu M, Bergmeir C, Ananda-Rajah M.

J Clin Med. 2019 Sep 5;8(9). pii: E1390. doi: 10.3390/jcm8091390.

2.

Contemporary analysis of functional immune recovery to opportunistic and vaccine-preventable infections after allogeneic haemopoietic stem cell transplantation.

de Silva HD, Ffrench RA, Korem M, Orlowski E, Curtis DJ, Spencer A, Avery S, Patil S, Morrissey CO.

Clin Transl Immunology. 2018 Oct 5;7(10):e1040. doi: 10.1002/cti2.1040. eCollection 2018.

3.

Standing up to the cardiometabolic consequences of hematological cancers.

Howden EJ, La Gerche A, Arthur JF, McMullen JR, Jennings GL, Dunstan DW, Owen N, Avery S, Kingwell BA.

Blood Rev. 2018 Sep;32(5):349-360. doi: 10.1016/j.blre.2018.02.005. Epub 2018 Feb 21. Review.

PMID:
29496356
4.

Defibrotide for the treatment of sinusoidal obstruction syndrome: evaluation of response to therapy and patient outcomes.

Coutsouvelis J, Avery S, Dooley M, Kirkpatrick C, Spencer A.

Support Care Cancer. 2018 Mar;26(3):947-955. doi: 10.1007/s00520-017-3915-1. Epub 2017 Oct 11.

PMID:
29022099
5.

The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study.

Tan P, Tiong IS, Fleming S, Pomilio G, Cummings N, Droogleever M, McManus J, Schwarer A, Catalano J, Patil S, Avery S, Spencer A, Wei A.

Oncotarget. 2016 Nov 29;8(32):52269-52280. doi: 10.18632/oncotarget.13699. eCollection 2017 Aug 8.

6.

Dapsone and azole interactions: A clinical perspective.

Corallo C, Coutsouvelis J, Avery S, Morgan S, Morrissey O.

J Oncol Pharm Pract. 2018 Dec;24(8):637-640. doi: 10.1177/1078155217722048. Epub 2017 Jul 21. Review.

PMID:
28732451
7.

Cost-effectiveness of a lifestyle modification program in long-term survivors of hemopoietic stem cell transplantation.

Gao L, Moodie M, Brown V, Avery S.

Clin Transplant. 2017 Sep;31(9). doi: 10.1111/ctr.13049. Epub 2017 Jul 27.

PMID:
28678411
8.

Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals.

Koelsch KK, Rasmussen TA, Hey-Nguyen WJ, Pearson C, Xu Y, Bailey M, Marks KH, Sasson SC, Taylor MS, Tantau R, Obeid S, Milner B, Morrissey O, Pinto AN, Suzuki K, Busch MP, Keating SM, Kaiser P, Yukl S, Wong JK, Hiener BM, Palmer S, Zaunders J, Post JJ, Chan DJ, Avery S, Milliken ST, Kelleher AD, Lewin SR, Cooper DA.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):328-337. doi: 10.1097/QAI.0000000000001381.

9.

Defibrotide for the management of sinusoidal obstruction syndrome in patients who undergo haemopoietic stem cell transplantation.

Coutsouvelis J, Avery S, Dooley M, Kirkpatrick C, Spencer A.

Cancer Treat Rev. 2016 Nov;50:200-204. doi: 10.1016/j.ctrv.2016.09.014. Epub 2016 Sep 30. Review.

PMID:
27721142
10.

Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia.

Fleming S, Ong DM, Jackson K, Avery S, Mollee P, Marlton P, Kennedy G, Wei AH.

Br J Haematol. 2017 Apr;177(2):328-330. doi: 10.1111/bjh.14063. Epub 2016 Mar 31. No abstract available.

PMID:
27029236
11.

Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia.

Ling VY, Lee D, Mcquilten Z, Avery S, Low M, Cody SH, Nguyen T, Mclean C, Gorniak M, Wei A, Ting SB.

Am J Hematol. 2015 Dec;90(12):E219-20. doi: 10.1002/ajh.24179. Epub 2015 Oct 8. No abstract available.

12.

Implementing novel models of posttreatment care for cancer survivors: Enablers, challenges and recommendations.

Jefford M, Kinnane N, Howell P, Nolte L, Galetakis S, Bruce Mann G, Naccarella L, Lai-Kwon J, Simons K, Avery S, Thompson K, Ashley D, Haskett M, Davies E, Whitfield K.

Asia Pac J Clin Oncol. 2015 Dec;11(4):319-27. doi: 10.1111/ajco.12406. Epub 2015 Aug 6.

PMID:
26245952
13.

Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation.

Pham T, Patil S, Fleming S, Avery S, Walker P, Wei A, Curtis D, Stuart G, Klarica D, O'Brien M, Morris K, Das T, Bollard G, Muirhead J, Coutsouvelis J, Spencer A.

Transfusion. 2015 Nov;55(11):2709-13. doi: 10.1111/trf.13233. Epub 2015 Jul 14.

PMID:
26173921
14.

Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML.

Rijal S, Fleming S, Cummings N, Rynkiewicz NK, Ooms LM, Nguyen NY, Teh TC, Avery S, McManus JF, Papenfuss AT, McLean C, Guthridge MA, Mitchell CA, Wei AH.

Blood. 2015 Apr 30;125(18):2815-24. doi: 10.1182/blood-2014-09-603555. Epub 2015 Mar 3.

PMID:
25736313
15.

Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia.

Wei A, Tan P, Perruzza S, Govindaraj C, Fleming S, McManus J, Avery S, Patil S, Stevenson W, Plebanski M, Spencer A.

Br J Haematol. 2015 Apr;169(2):199-210. doi: 10.1111/bjh.13281. Epub 2015 Feb 2.

PMID:
25643589
16.

Response to Salander's Letter to the Editor.

Pillay B, Lee SJ, Katona L, De Bono S, Burney S, Avery S.

Psychooncology. 2014 Dec;23(12):1441-2. doi: 10.1002/pon.3715. No abstract available.

PMID:
25476130
17.

A prospective study of the relationship between sense of coherence, depression, anxiety, and quality of life of haematopoietic stem cell transplant patients over time.

Pillay B, Lee SJ, Katona L, De Bono S, Burney S, Avery S.

Psychooncology. 2015 Feb;24(2):220-7. doi: 10.1002/pon.3633. Epub 2014 Jul 23.

PMID:
25052297
18.

Psychosocial factors predicting survival after allogeneic stem cell transplant.

Pillay B, Lee SJ, Katona L, Burney S, Avery S.

Support Care Cancer. 2014 Sep;22(9):2547-55. doi: 10.1007/s00520-014-2239-7. Epub 2014 Apr 16.

PMID:
24736876
19.

Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocol.

Hocking J, Schwarer AP, Gasiorowski R, Patil S, Avery S, Gibson J, Iland H, Ho PJ, Joshua D, Muirhead J, Lai H, Irving I.

Leuk Lymphoma. 2014 Dec;55(12):2801-7. doi: 10.3109/10428194.2014.894191. Epub 2014 Mar 19.

PMID:
24528220
20.

Psychosocial factors associated with quality of life in allogeneic stem cell transplant patients prior to transplant.

Pillay B, Lee SJ, Katona L, Burney S, Avery S.

Psychooncology. 2014 Jun;23(6):642-9. doi: 10.1002/pon.3462. Epub 2013 Dec 18.

PMID:
24375571

Supplemental Content

Loading ...
Support Center